Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumana Srivatsa

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Elife|January 4, 2018
Context-dependent deposition and regulation of mRNAs in P-bodiesCongwei Wang, Fabian Schmich, Sumana Srivatsa, et al.
Elife|August 24, 2018
Correction: Context-dependent deposition and regulation of mRNAs in P-bodiesCongwei Wang, Fabian Schmich, Sumana Srivatsa, et al.
Bioinformatics (Oxford, England)|June 29, 2018
Improved pathway reconstruction from RNA interference screens by exploiting off-target effectsSumana Srivatsa, Jack Kuipers, Fabian Schmich, et al.
Clinical Epigenetics|May 27, 2023
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancersMayuri Inchanalkar, Sumana Srivatsa, Srikant Ambatipudi, et al.
Nature Communications|December 14, 2022
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screensSumana Srivatsa, Hesam Montazeri, Gaia Bianco, et al.
Cell Stem Cell|March 7, 2020
Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β ResistanceTill Ringel, Nina Frey, Femke Ringnalda, et al.
Nucleic Acids Research|July 27, 2021
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screensHesam Montazeri, Mairene Coto-Llerena, Gaia Bianco, et al.
Communications Biology|July 5, 2022
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancersGaia Bianco, Mairene Coto-Llerena, John Gallon, et al.
Communications Biology|April 20, 2022
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancersGaia Bianco, Mairene Coto-Llerena, John Gallon, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Elife|January 4, 2018
Context-dependent deposition and regulation of mRNAs in P-bodiesCongwei Wang, Fabian Schmich, Sumana Srivatsa, et al.
Elife|August 24, 2018
Correction: Context-dependent deposition and regulation of mRNAs in P-bodiesCongwei Wang, Fabian Schmich, Sumana Srivatsa, et al.
Bioinformatics (Oxford, England)|June 29, 2018
Improved pathway reconstruction from RNA interference screens by exploiting off-target effectsSumana Srivatsa, Jack Kuipers, Fabian Schmich, et al.
Clinical Epigenetics|May 27, 2023
Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancersMayuri Inchanalkar, Sumana Srivatsa, Srikant Ambatipudi, et al.
Nature Communications|December 14, 2022
Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screensSumana Srivatsa, Hesam Montazeri, Gaia Bianco, et al.
Cell Stem Cell|March 7, 2020
Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β ResistanceTill Ringel, Nina Frey, Femke Ringnalda, et al.
Nucleic Acids Research|July 27, 2021
Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screensHesam Montazeri, Mairene Coto-Llerena, Gaia Bianco, et al.
Communications Biology|July 5, 2022
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancersGaia Bianco, Mairene Coto-Llerena, John Gallon, et al.
Communications Biology|April 20, 2022
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancersGaia Bianco, Mairene Coto-Llerena, John Gallon, et al.
Pageof 1